Published in Antimicrob Agents Chemother on May 01, 1977
Pharmacology and efficacy of netilmicin. Antimicrob Agents Chemother (1978) 1.17
Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol (1966) 159.00
Changing ecology of bacterial infections as related to antibacterial therapy. J Infect Dis (1970) 7.72
LABORATORY AND CLINICAL STUDIES OF GENTAMICIN, A NEW BROAD-SPECTRUM ANTIBIOTIC. Ann Intern Med (1963) 4.19
GENTAMICIN: ACTIVITY IN VITRO AND OBSERVATIONS IN 26 PATIENTS. Am J Med Sci (1964) 3.88
Effect of the concentrations of magnesium and calcium on the in-vitro susceptibility of Pseudomonas aeruginosa to gentamicin. J Infect Dis (1971) 3.41
Current therapeutics. 234. Gentamicin. Practitioner (1967) 2.54
Gentamicin-resistant Pseudomonas aeruginosa and Serratia marcescens in a general hospital. Lancet (1976) 2.07
Ototoxicity of gentamicin in man: a survey and controlled analysis of clinical experience in the United States. J Infect Dis (1971) 1.97
Nephrotoxicity of aminoglycosides and gentamicin. J Infect Dis (1969) 1.77
A virulent nosocomial Klebsiella with a transferable R factor for gentamicin: emergence and suppression. J Infect Dis (1971) 1.73
Renal insufficiency associated with gentamicin therapy. J Infect Dis (1971) 1.59
Letter: Gentamicin-resistant Staphylococci. Lancet (1976) 1.18
Relative antagonism in vitro of calcium in serum to the bactericidal activities of gentamicin and tobramycin on Pseudomonas aeruginosa. Chemotherapy (1973) 1.02
Letter: Gentamicin and neuromuscular blockade. Ann Intern Med (1976) 0.83
Agranulocytosis associated with gentamicin. JAMA (1975) 0.79
New antibacterial treatment of nosocomial infections. Bull N Y Acad Med (1975) 0.79
Letter: Activities of tobramycin and amikacin against gentamicin-resistant gram-negative bacilli. Lancet (1976) 0.79
Nosocomial klebsiella infections: intestinal colonization as a reservoir. Ann Intern Med (1971) 6.55
5-fluorocytosine: an oral antifungal compound. A report on clinical and laboratory experience. Ann Intern Med (1972) 3.55
Infectious complications in renal transplant recipients. Transplant Proc (1973) 3.26
The Klebsiella-Enterobacter-Serratia division. Biochemical and serologic characteristics and susceptibility to antibiotics. Ann Intern Med (1966) 3.07
The Klebsiella-Enterobacter-Serratia division. Clinical and epidemiologic characteristics. Ann Intern Med (1966) 2.92
In vitro effects of carbenicillin combined with gentamicin or polymyxin B against Pseudomonas aeruginosa. Appl Microbiol (1969) 2.43
A comparison of single-dose cefixime with ceftriaxone as treatment for uncomplicated gonorrhea. The Gonorrhea Treatment Study Group. N Engl J Med (1991) 2.30
Fluorescent monoclonal antibody for confirmation of Neisseria gonorrhoeae cultures. J Clin Microbiol (1987) 2.21
Comparative in vitro studies of Ro 13-9904, a new cephalosporin derivative. Antimicrob Agents Chemother (1981) 2.11
In vitro comparison of cefoxitin, cefamandole, cephalexin, and cephalothin. Antimicrob Agents Chemother (1976) 2.04
Spontaneous bacterial peritonitis. A review of 28 cases with emphasis on improved survival and factors influencing prognosis. Am J Med (1978) 2.04
Application of four methods to the study of the susceptibility of yeast to 5-fluorocytosine. Antimicrob Agents Chemother (Bethesda) (1970) 1.97
Epidemiology of Legionnaires' disease. Ann Intern Med (1979) 1.97
Factors related to genital Chlamydia trachomatis and its diagnosis by culture in a sexually transmitted disease clinic. Am J Epidemiol (1988) 1.92
Rapid sulfonamide disc sensitivity test for meningococci. Appl Microbiol (1968) 1.87
Pseudomonas pseudomallei: susceptibility to chemotherapeutic agents. J Infect Dis (1970) 1.86
An outbreak in 1965 of severe respiratory illness caused by the Legionnaires' disease bacterium. J Infect Dis (1978) 1.84
Surveillance of nosocomial infections in community hospitals. I. Surveillance methods, effectiveness, and initial results. J Infect Dis (1969) 1.80
Carbenicillin and gentamicin: pharmacologic studies in patients with cystic fibrosis and pseudomonas pulmonary infections. J Pediatr (1971) 1.75
Effects of ampicillin-amikacin and ampicillin-rifampin on enterococci. Antimicrob Agents Chemother (1976) 1.71
Bacillus cereus pneumonia and bacteremia. A case report. Am Rev Respir Dis (1971) 1.70
Immunization against influenza: rationale and recommendations. J Infect Dis (1971) 1.65
In vitro sensitivity of Torulopsis glabrata to amphotericin B, 5-fluorocytosine, and clotrimazole (Bay 5097). Appl Microbiol (1971) 1.60
Cerebrospinal fluid shunt infections with anaerobic diphtheroids (Propionibacterium species). J Neurosurg (1976) 1.51
Outbreak of a multiply resistant Acinetobacter in a surgical intensive care unit: epidemiology and control. Heart Lung (1978) 1.49
Carbenicillin: a clinical and laboratory evaluation. Ann Intern Med (1970) 1.48
Letter: The issue of prophylaxis of neonatal group B streptococcal infections. J Pediatr (1973) 1.48
In-vitro and in-vivo studies of resistance to rifampin in meningococci. J Infect Dis (1971) 1.46
Protection against Hong Kong influneza by adjuvant vaccine containing A2-Ann Arbor-67. Bull World Health Organ (1969) 1.44
Unusual occurrence of neonatal meningitis due to group B beta-hemolytic streptococci. Pediatrics (1966) 1.37
Efficacy of "Hong Kong" vaccine in preventing "England" variant influenza A in 1972. N Engl J Med (1973) 1.33
Infectious risk factors in the immunosuppressed host. Am J Med (1973) 1.33
Antigenic drift and efficacy of influenza virus vaccines, 1976--1977. J Infect Dis (1978) 1.32
Multidrug-resistant Proteus rettgeri: an emerging problem. Ann Intern Med (1976) 1.27
Anogenital infection with Neisseria meningitidis in homosexual men. J Infect Dis (1978) 1.27
In vitro evaluations of condoms with and without nonoxynol 9 as physical and chemical barriers against Chlamydia trachomatis, herpes simplex virus type 2, and human immunodeficiency virus. Sex Transm Dis (1989) 1.25
Unsuspected Chlamydia trachomatis infection in heterosexual men attending a sexually transmitted diseases clinic: evaluation of risk factors and screening methods. Sex Transm Dis (1991) 1.23
Single-dose ceftriaxone to eradicate pharyngeal Neisseria meningitidis. Lancet (1984) 1.20
The current status of BCG immunization against tuberculosis. Annu Rev Med (1977) 1.18
Antibiotic susceptibility of Bacillus species. J Infect Dis (1971) 1.13
Torulopsis glabrata--an opportunistic pathogen in man. N Engl J Med (1970) 1.10
Feasibility and yield of screening urine for Chlamydia trachomatis by polymerase chain reaction among high-risk male youth in field-based and other nonclinic settings. A new strategy for sexually transmitted disease control. Sex Transm Dis (1997) 1.09
Impaired serum antibody response to inactivated influenza A and B vaccine in renal transplant recipients. Infect Immun (1977) 1.08
Comparative study of ceftriaxone and spectinomycin for treatment of pharyngeal and anorectal gonorrhea. JAMA (1985) 1.06
Sero-epidemiologic studies of meningococcal infection with the direct hemagglutination test. J Infect Dis (1971) 1.00
Salmonellae on the grocery shelf. Ann Intern Med (1967) 0.99
Characterization of an ampicillin-resistant Haemophilus influenzae type B. Antimicrob Agents Chemother (1976) 0.99
Immunofluorescence of yeast in urine. J Clin Microbiol (1976) 0.99
Septicemia in renal transplant recipients. Arch Surg (1973) 0.98
Comparative study of ceftriaxone and aqueous procaine penicillin G in the treatment of uncomplicated gonorrhea in women. Antimicrob Agents Chemother (1983) 0.97
Serologic studies in suspected visceral candidiasis. Arch Intern Med (1975) 0.95
Oral rifampin and trimethoprim/sulfamethoxazole therapy in asymptomatic carriers of methicillin-resistant Staphylococcus aureus infections. West J Med (1984) 0.94
Studies of inactivated influenza virus vaccines in hospital employees: reactogenicity and absenteeism. J Infect Dis (1977) 0.93
Pneumococcal vaccine: an emerging consensus. Ann Intern Med (1988) 0.92
Haemophilus influenzae pericarditis and empyema with thyroiditis in an adult. JAMA (1974) 0.91
The social evolution of the Infectious Diseases Society of America. J Infect Dis (1985) 0.89
From the Infectious Diseases Society of America. Hospital epidemiology and infection control: the changing role of the specialist in infectious diseases. J Infect Dis (1981) 0.89
Lessons learned from a review of the development of selected vaccines. National Vaccine Advisory Committee. Pediatrics (1999) 0.89
Hospital policies on HIV antibody testing. JAMA (1988) 0.88
Immunization--an adult thing to do. J Infect Dis (1985) 0.88
Nosocomial infections--a 1980 view: progress, priorities and prognosis. Am J Med (1981) 0.86
Auxotype/serovar diversity and antimicrobial resistance of Neisseria gonorrhoeae in two mid-sized American cities. Sex Transm Dis (1987) 0.86
Microbiologic sampling of the hospital environment. Health Lab Sci (1974) 0.85
The role of infection in critical care. Anesthesiology (1977) 0.85
General comments on the study on the efficacy of nosocomial infection control (SENIC Project). Am J Epidemiol (1980) 0.82
Respiratory tract infections. Goals for 1995. Am J Med (1985) 0.81
An influenza A epidemic caused by H1N1 virus. Mil Med (1980) 0.81
In vitro comparison of rosamicin and erythromycin against urinary tract pathogens. Antimicrob Agents Chemother (1979) 0.80
Hospital infection control begins with good surveillance. Hospitals (1967) 0.80
Pneumococcal vaccine: the evidence mounts. Ann Intern Med (1986) 0.79
New antibacterial treatment of nosocomial infections. Bull N Y Acad Med (1975) 0.79
Standards for hospital infection control. Ann Intern Med (1978) 0.79
Empyema necessitatis. Am Rev Respir Dis (1970) 0.79
Neisseria mule, horse, or donkey. J Clin Microbiol (1988) 0.78
Letter: Meningococcal prophylaxis. JAMA (1975) 0.78
Comparison of secular trends in pneumococcal serotypes causing invasive disease in Denver, Colorado (1971-2004) and serotype coverage by marketed pneumococcal vaccines. Clin Microbiol Infect (2006) 0.78
Microbiological sampling. Hospitals (1970) 0.78
Antibody response of young adults to experimental influenza A/New Jersey/76 virus vaccines. J Infect Dis (1977) 0.77
Comparative study of cefoperazone and spectinomycin for treatment of uncomplicated gonorrhea in men. Antimicrob Agents Chemother (1986) 0.76
Nosocomial infections. N Engl J Med (1982) 0.76
Whither infectious diseases? Some data at last. J Infect Dis (1992) 0.75
Hospital infection control: coming of age. Am J Infect Control (1993) 0.75
Comparative activity in vitro of ticarcillin, BL-P1654, and carbenicillin. Antimicrob Agents Chemother (1976) 0.75
Treatment of uncomplicated gonorrhea with single-dose imipenem-cilastatin. Antimicrob Agents Chemother (1988) 0.75
Carbenicillin in therapy of systemic infections due to Pseudomonas. J Infect Dis (1970) 0.75
Current problems and approaches to diagnosis of infection in renal transplant recipients. Transplant Proc (1972) 0.75
Staphylococcal interference studies. Am J Epidemiol (1968) 0.75
Recommendations for the control of rubella within hospitals. Infect Control (1982) 0.75
Nosocomial infections--1981. J Antimicrob Chemother (1982) 0.75
Combined action of 6-mercaptopurine and antibiotics on gram-negative bacteria in vitro. Proc Soc Exp Biol Med (1972) 0.75
Hospital infections. Dis Mon (1972) 0.75
George Gee Jackson: an appreciation. J Infect Dis (1984) 0.75
Rifampin and meningococci: the price of prophylaxis. Mil Med (1971) 0.75
Hospital epidemiology in the work of Maxwell Finland. J Infect Dis (1972) 0.75